LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 27.11 | 771.67 | 1320 | 2675 | 0.4934 | 0.3489 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.33 | 771.67 | 1188 | 2939 | 0.4042 | 0.2506 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.33 | 771.67 | 1363 | 2939 | 0.4637 | 0.3429 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.55 | 771.67 | 1220 | 3196 | 0.3816 | 0.2503 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.55 | 771.67 | 1238 | 3196 | 0.3873 | 0.2593 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.78 | 771.67 | 1193 | 3499 | 0.3409 | 0.2211 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.78 | 771.67 | 1253 | 3499 | 0.3580 | 0.2489 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.00 | 771.67 | 1177 | 3884 | 0.3030 | 0.1985 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.00 | 771.67 | 1323 | 3884 | 0.3406 | 0.2601 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.22 | 771.67 | 1213 | 4299 | 0.2821 | 0.2002 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.22 | 771.67 | 1347 | 4299 | 0.3133 | 0.2521 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.44 | 771.67 | 1203 | 4738 | 0.2539 | 0.1848 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.44 | 771.67 | 1327 | 4738 | 0.2801 | 0.2300 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.67 | 771.67 | 1214 | 5155 | 0.2355 | 0.1798 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 42.67 | 771.67 | 1276 | 5155 | 0.2475 | 0.2015 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.89 | 771.67 | 1266 | 5541 | 0.2285 | 0.1901 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 44.89 | 771.67 | 1349 | 5541 | 0.2434 | 0.2170 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.11 | 771.67 | 1250 | 5941 | 0.2104 | 0.1780 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 47.11 | 771.67 | 1451 | 5941 | 0.2442 | 0.2392 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.33 | 771.67 | 1324 | 6392 | 0.2071 | 0.1936 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 49.33 | 771.67 | 1510 | 6392 | 0.2362 | 0.2462 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.55 | 771.67 | 1330 | 6829 | 0.1947 | 0.1889 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 51.55 | 771.67 | 1490 | 6829 | 0.2182 | 0.2326 | MN20160304_L01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 771.67 | 1349 | 7256 | 0.1859 | 0.1886 | MN20160304_L01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 53.77 | 771.67 | 1516 | 7256 | 0.2089 | 0.2323 | MN20160304_L01 | I20 |